BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38554324)

  • 1. Single-nucleotide polymorphism in CYP1A1, CYP1B1, CYP2B6, CYP2C8, and CYP2C9 genes and their association with gastrointestinal cancer: A hospital-based case-control study.
    Patil MN; Datkhile KD; Gudur AK; Gudur RA; Patil SR
    J Cancer Res Ther; 2024 Jan; 20(1):216-223. PubMed ID: 38554324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control study.
    Datkhile KD; Patil SR; Patil MN; Durgawale PP; Jagdale NJ; Deshmukh VN; More AL; Gudur RA; Gudur AK
    J Cancer Res Ther; 2023 Oct; 19(7):1925-1930. PubMed ID: 38376298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population.
    Arun Kumar AS; Kumar SS; Umamaheswaran G; Kesavan R; Balachandar J; Adithan C
    Pharmacol Rep; 2015 Feb; 67(1):97-101. PubMed ID: 25560582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence Polymorphism in Xenobiotic Metabolising Genes in Iraqi Colorectal Cancer Patients.
    Ibrahem SQ; Al-Dalawi ZT; Bahaaldin AS
    Asian Pac J Cancer Prev; 2021 Apr; 22(4):1203-1210. PubMed ID: 33906313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
    Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
    Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population.
    Polonikov A; Kharchenko A; Bykanova M; Sirotina S; Ponomarenko I; Bocharova A; Vagaytseva K; Stepanov V; Bushueva O; Churnosov M; Solodilova M
    Gene; 2017 Sep; 627():451-459. PubMed ID: 28687336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D6 and CYP2E1 Gene Polymorphisms and their Association with Cervical Cancer Susceptibility: A Hospital Based Case-Control Study from South-Western Maharashtra.
    Datkhile KD; Durgawale PP; Gudur RA; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2022 Aug; 23(8):2591-2597. PubMed ID: 36037111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population.
    Polonikov A; Bykanova M; Ponomarenko I; Sirotina S; Bocharova A; Vagaytseva K; Stepanov V; Churnosov M; Bushueva O; Solodilova M; Shvetsov Y; Ivanov V
    Clin Exp Hypertens; 2017; 39(4):306-311. PubMed ID: 28513222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles.
    Chamboko CR; Veldman W; Tata RB; Schoeberl B; Tastan Bishop Ö
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of CYP2C8 and CYP2C9 amino acid substitution alleles in South Indian diabetes patients: A genotypic and computational protein phenotype study.
    Rao DK; Murthy DK; Shaik NS; Banaganapalli B; Konda K; Rao HP; Ganti E; Ahmed Awan Z; A El-Harouni A; Elango R; Ali Khan I; Shaik NA
    Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1171-1179. PubMed ID: 28686288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP1A1m1 and CYP2C9*2 and *3 polymorphism and risk to develop ARV-associated hepatotoxicity and its severity.
    Singh H; Lata S; Nema V; Samani D; Ghate M; Gangakhedkar RR
    APMIS; 2017 Jun; 125(6):523-535. PubMed ID: 28370504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of single nucleotide polymorphisms in estrogen-metabolizing enzymes and susceptibility to uterine leiomyoma in Han Chinese: a case-control study.
    Shen Y; Xu Q; Ren M; Cai Y; Xu J
    J Obstet Gynaecol Res; 2014 Apr; 40(4):1077-84. PubMed ID: 24320736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superoxide Dismutase (rs2070424, rs4880, rs2536512) and Catalase (rs794316, rs1001179) SNPs and their Association with Breast Cancer Risk: Findings from a Hospital Based Case-Control Study.
    Datkhile KD; Gudur RA; Bhosale SJ; Gudur AK; Durgawale PP; Jagdale NJ; More AL; Patil SR
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):175-184. PubMed ID: 38285782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
    Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
    Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CYP gene polymorphisms with breast cancer risk and prognostic factors in the Jordanian population.
    Al-Eitan LN; Rababa'h DM; Alghamdi MA; Khasawneh RH
    BMC Med Genet; 2019 Sep; 20(1):148. PubMed ID: 31477036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of CYP1A1 T3801C (rs4646903) variant with the susceptibility and progression of B-chronic lymphocytic Leukemia (B-CLL) in the Egyptian population.
    Al-Adl M; El-Said A; El-Sebaie A; Refaat S; Youssef MM
    Gene; 2023 Oct; 883():147673. PubMed ID: 37506988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the cytochrome P450 CYP2C8*2 allele in Brazzaville, Republic of Congo.
    Peko SM; Ntoumi F; Vouvoungui C; Nderu D; Kobawila SC; Velavan TP; Koukouikila-Koussounda F
    Int J Infect Dis; 2019 Aug; 85():49-53. PubMed ID: 31078747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) polymorphisms and bladder cancer risk in a Turkish population.
    Berber U; Yilmaz I; Yilmaz O; Haholu A; Kucukodaci Z; Ates F; Demirel D
    Asian Pac J Cancer Prev; 2013; 14(6):3925-9. PubMed ID: 23886208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
    Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.